Norman C. Selby - 10 Jun 2021 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Norman C. Selby
Issuer symbol
N/A
Transactions as of
10 Jun 2021
Net transactions value
$0
Form type
4
Filing time
11 Jun 2021, 16:16:19 UTC
Previous filing
18 May 2021
Next filing
16 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Option (right to buy) Award $0 +30,000 $0.000000 30,000 10 Jun 2021 Common Stock 30,000 $3.43 Direct F1
transaction INFI Stock Option (right to buy) Award $0 +10,000 $0.000000 10,000 10 Jun 2021 Common Stock 10,000 $3.43 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer.
F2 The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as Lead Independent Director of the issuer's Board of Directors.